Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing

Annalisa Buniello, Neil J. Ingham, Morag A. Lewis, Andreea C Huma, Raquel Martínez‐Vega, Isabel Varela‐Nieto, Gema Vizcay‐Barrena, Roland A. Fleck, Oliver Houston, Tanaya Bardhan,

EMBO Molecular Medicine · 2016 · 51 citations · 60 references

DOIFull text

Open access

Concepts

Abstract

WBP2 encodes the WW domain-binding protein 2 that acts as a transcriptional coactivator for estrogen receptor α (ESR1) and progesterone receptor (PGR). We reported that the loss of Wbp2 expression leads to progressive high-frequency hearing loss in mouse, as well as in two deaf children, each carrying two different variants in the WBP2 gene. The earliest abnormality we detect in Wbp2-deficient mice is a primary defect at inner hair cell afferent synapses. This study defines a new gene involved in the molecular pathway linking hearing impairment to hormonal signalling and provides new therapeutic targets.

References

60